# Virus DNX2401 and Temozolomide in Recurrent Glioblastoma

> **NCT01956734** · PHASE1 · COMPLETED · sponsor: **Clinica Universidad de Navarra, Universidad de Navarra** · enrollment: 31 (estimated)

## Conditions studied

- Glioblastoma Multiforme
- Recurrent Tumor

## Interventions

- **PROCEDURE:** DNX2401 and Temozolomide

## Key facts

- **NCT ID:** NCT01956734
- **Lead sponsor:** Clinica Universidad de Navarra, Universidad de Navarra
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2015-12
- **Final completion:** 2017-03
- **Target enrollment:** 31 (ESTIMATED)
- **Last updated:** 2017-10-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01956734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01956734, "Virus DNX2401 and Temozolomide in Recurrent Glioblastoma". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01956734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*